Schools Adopt Face Recognition in the Name of Fighting Covid
By Gregory Barber,
Wired
| 11. 03. 2020
IN JUNE, THE school board in Rio Rancho, New Mexico, was facing a series of votes on the budget for an elaborate and expensive reopening plan. Among the big-ticket items was a tablet designed to screen students and staff for fevers. The devices were sold by a company named OneScreen, which supplies schools with technology including “smart” whiteboards and attendance apps. But this spring, it had pivoted. Its new product, called GoSafe, could scan foreheads for elevated temperatures and detect when students aren’t wearing masks. It also came with a bonus: “top-of-the-line” facial recognition, as a local vendor described it to the school board.
District officials considered this a selling point. The tablets were pricey—$161,000 for 71 devices—even amid the district’s bulk orders of hand sanitizer and protective equipment. But they would get kids through school doors more efficiently than handheld thermometers. The facial recognition tech offered another benefit: The money would not necessarily go to waste as soon as there was a Covid-19 vaccine. The district could use the devices for other things, like taking attendance or preventing intruders...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...